Lynx1 Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,436
Closed -$621K 24
2024
Q3
$621K Sell
37,436
-6,063
-14% -$88.6K 0.22% 12
2024
Q2
$427K Sell
43,499
-66,241
-60% -$747K 0.15% 13
2024
Q1
$1.61M Sell
109,740
-12,458
-10% -$173K 0.41% 14
2023
Q4
$1.78M Hold
122,198
0.7% 12
2023
Q3
$2.91M Hold
122,198
1.93% 9
2023
Q2
$1.62M Buy
122,198
+33,852
+38% +$2.05M 1.06% 11
2023
Q1
$6.9M Buy
88,346
+17,989
+26% +$2.08M 5.75% 6
2022
Q4
$5.85M Buy
70,357
+26,418
+60% +$2.12M 5.06% 7
2022
Q3
$4.04M Buy
43,939
+3,647
+9% +$470K 3.65% 8
2022
Q2
$6.03M Buy
40,292
+26,088
+184% +$4.76M 5.14% 7
2022
Q1
$3.44M Buy
14,204
+9,413
+196% +$2.47M 3.2% 10
2021
Q4
$1.45M Buy
+4,791
New +$1.53M 1.26% 9

Other funds holding PVLA